Industry Research Reports
Global Heparin Sodium Market Research Report 2025
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 91 Pages
Report ld: 3469503
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Heparin Sodium Market Size(US$)
CAGR 2025-2031
6.2%
Market Size,2031
USD 4,560
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,185 million
Market Forecast in 2031(Value)
US$ 4,560 million
CAGR
6.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Heparin Sodium was valued at US$ 3018 million in the year 2024 and is projected to reach a revised size of US$ 4560 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioiberica, Nanjing King-friend, Dongcheng Biochemicals and Changzhou Qianhong Bio-pharma. Global top five manufacturers hold a share about 54%. Europe is the largest market, with a share about 55%, followed by China and North America, with share 22% and 13%, separately. In term of application, the largest application is Low Molecular Weight Heparin Preparations, with a share of 93%.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Heparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium.
The Heparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink
Nanjing King-friend
Bioiberica
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Pfizer
Changshan Biochemical
Aspen Oss
Opocrin
Qingdao Jiulong Biopharmaceutical
Yino Pharma Limited
Dongying Tiandong Pharmaceutical
Xinbai Pharmaceuticals
Laboratorios Farmaceuticos ROVI
Sichuan Deebio
Segment by Type
Type A
Type B
Segment by Application
Standard Heparin Preparation
Low Molecular Weight Heparin Preparations
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Heparin Sodium Market Overview
1.1 Product Definition
1.2 Heparin Sodium by Type
1.2.1 Global Heparin Sodium Market Value Comparison by Type (2024 VS 2031)
1.2.2 Type A
1.2.3 Type B
1.3 Heparin Sodium by Application
1.3.1 Global Heparin Sodium Market Value by Application (2024 VS 2031)
1.3.2 Standard Heparin Preparation
1.3.3 Low Molecular Weight Heparin Preparations
1.4 Global Heparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Heparin Sodium Revenue 2020-2031
1.4.2 Global Heparin Sodium Sales 2020-2031
1.4.3 Global Heparin Sodium Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heparin Sodium Market Competition by Manufacturers
2.1 Global Heparin Sodium Sales Market Share by Manufacturers (2020-2025)
2.2 Global Heparin Sodium Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Heparin Sodium Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Heparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin Sodium, Product Type & Application
2.7 Global Key Manufacturers of Heparin Sodium, Date of Enter into This Industry
2.8 Global Heparin Sodium Market Competitive Situation and Trends
2.8.1 Global Heparin Sodium Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heparin Sodium Players Market Share by Revenue
2.8.3 Global Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heparin Sodium Market Scenario by Region
3.1 Global Heparin Sodium Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Heparin Sodium Sales by Region: 2020-2031
3.2.1 Global Heparin Sodium Sales by Region: 2020-2025
3.2.2 Global Heparin Sodium Sales by Region: 2026-2031
3.3 Global Heparin Sodium Revenue by Region: 2020-2031
3.3.1 Global Heparin Sodium Revenue by Region: 2020-2025
3.3.2 Global Heparin Sodium Revenue by Region: 2026-2031
3.4 North America Heparin Sodium Market Facts & Figures by Country
3.4.1 North America Heparin Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heparin Sodium Sales by Country (2020-2031)
3.4.3 North America Heparin Sodium Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin Sodium Market Facts & Figures by Country
3.5.1 Europe Heparin Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heparin Sodium Sales by Country (2020-2031)
3.5.3 Europe Heparin Sodium Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Heparin Sodium Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heparin Sodium Sales by Region (2020-2031)
3.6.3 Asia Pacific Heparin Sodium Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Sodium Market Facts & Figures by Country
3.7.1 Latin America Heparin Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heparin Sodium Sales by Country (2020-2031)
3.7.3 Latin America Heparin Sodium Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heparin Sodium Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heparin Sodium Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Sodium Sales by Type (2020-2031)
4.1.1 Global Heparin Sodium Sales by Type (2020-2025)
4.1.2 Global Heparin Sodium Sales by Type (2026-2031)
4.1.3 Global Heparin Sodium Sales Market Share by Type (2020-2031)
4.2 Global Heparin Sodium Revenue by Type (2020-2031)
4.2.1 Global Heparin Sodium Revenue by Type (2020-2025)
4.2.2 Global Heparin Sodium Revenue by Type (2026-2031)
4.2.3 Global Heparin Sodium Revenue Market Share by Type (2020-2031)
4.3 Global Heparin Sodium Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heparin Sodium Sales by Application (2020-2031)
5.1.1 Global Heparin Sodium Sales by Application (2020-2025)
5.1.2 Global Heparin Sodium Sales by Application (2026-2031)
5.1.3 Global Heparin Sodium Sales Market Share by Application (2020-2031)
5.2 Global Heparin Sodium Revenue by Application (2020-2031)
5.2.1 Global Heparin Sodium Revenue by Application (2020-2025)
5.2.2 Global Heparin Sodium Revenue by Application (2026-2031)
5.2.3 Global Heparin Sodium Revenue Market Share by Application (2020-2031)
5.3 Global Heparin Sodium Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shenzhen Hepalink
6.1.1 Shenzhen Hepalink Company Information
6.1.2 Shenzhen Hepalink Description and Business Overview
6.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shenzhen Hepalink Heparin Sodium Product Portfolio
6.1.5 Shenzhen Hepalink Recent Developments/Updates
6.2 Nanjing King-friend
6.2.1 Nanjing King-friend Company Information
6.2.2 Nanjing King-friend Description and Business Overview
6.2.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nanjing King-friend Heparin Sodium Product Portfolio
6.2.5 Nanjing King-friend Recent Developments/Updates
6.3 Bioiberica
6.3.1 Bioiberica Company Information
6.3.2 Bioiberica Description and Business Overview
6.3.3 Bioiberica Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioiberica Heparin Sodium Product Portfolio
6.3.5 Bioiberica Recent Developments/Updates
6.4 Dongcheng Biochemicals
6.4.1 Dongcheng Biochemicals Company Information
6.4.2 Dongcheng Biochemicals Description and Business Overview
6.4.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dongcheng Biochemicals Heparin Sodium Product Portfolio
6.4.5 Dongcheng Biochemicals Recent Developments/Updates
6.5 Changzhou Qianhong Bio-pharma
6.5.1 Changzhou Qianhong Bio-pharma Company Information
6.5.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
6.5.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Heparin Sodium Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Changshan Biochemical
6.7.1 Changshan Biochemical Company Information
6.7.2 Changshan Biochemical Description and Business Overview
6.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changshan Biochemical Heparin Sodium Product Portfolio
6.7.5 Changshan Biochemical Recent Developments/Updates
6.8 Aspen Oss
6.8.1 Aspen Oss Company Information
6.8.2 Aspen Oss Description and Business Overview
6.8.3 Aspen Oss Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aspen Oss Heparin Sodium Product Portfolio
6.8.5 Aspen Oss Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Opocrin Heparin Sodium Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Qingdao Jiulong Biopharmaceutical
6.10.1 Qingdao Jiulong Biopharmaceutical Company Information
6.10.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Portfolio
6.10.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.11 Yino Pharma Limited
6.11.1 Yino Pharma Limited Company Information
6.11.2 Yino Pharma Limited Description and Business Overview
6.11.3 Yino Pharma Limited Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yino Pharma Limited Heparin Sodium Product Portfolio
6.11.5 Yino Pharma Limited Recent Developments/Updates
6.12 Dongying Tiandong Pharmaceutical
6.12.1 Dongying Tiandong Pharmaceutical Company Information
6.12.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
6.12.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.13 Xinbai Pharmaceuticals
6.13.1 Xinbai Pharmaceuticals Company Information
6.13.2 Xinbai Pharmaceuticals Description and Business Overview
6.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
6.13.5 Xinbai Pharmaceuticals Recent Developments/Updates
6.14 Laboratorios Farmaceuticos ROVI
6.14.1 Laboratorios Farmaceuticos ROVI Company Information
6.14.2 Laboratorios Farmaceuticos ROVI Description and Business Overview
6.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Laboratorios Farmaceuticos ROVI Heparin Sodium Product Portfolio
6.14.5 Laboratorios Farmaceuticos ROVI Recent Developments/Updates
6.15 Sichuan Deebio
6.15.1 Sichuan Deebio Company Information
6.15.2 Sichuan Deebio Description and Business Overview
6.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sichuan Deebio Heparin Sodium Product Portfolio
6.15.5 Sichuan Deebio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Sodium Industry Chain Analysis
7.2 Heparin Sodium Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Sodium Production Mode & Process Analysis
7.4 Heparin Sodium Sales and Marketing
7.4.1 Heparin Sodium Sales Channels
7.4.2 Heparin Sodium Distributors
7.5 Heparin Sodium Customer Analysis
8 Heparin Sodium Market Dynamics
8.1 Heparin Sodium Industry Trends
8.2 Heparin Sodium Market Drivers
8.3 Heparin Sodium Market Challenges
8.4 Heparin Sodium Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Heparin Sodium Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Heparin Sodium Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Heparin Sodium Market Competitive Situation by Manufacturers in 2024
Table 4. Global Heparin Sodium Sales (Million Units) of Key Manufacturers (2020-2025)
Table 5. Global Heparin Sodium Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Heparin Sodium Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Heparin Sodium Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Heparin Sodium Average Price (USD/Million Units) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Heparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heparin Sodium, Product Type & Application
Table 12. Global Key Manufacturers of Heparin Sodium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Heparin Sodium Sales by Region (2020-2025) & (Million Units)
Table 18. Global Heparin Sodium Sales Market Share by Region (2020-2025)
Table 19. Global Heparin Sodium Sales by Region (2026-2031) & (Million Units)
Table 20. Global Heparin Sodium Sales Market Share by Region (2026-2031)
Table 21. Global Heparin Sodium Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Heparin Sodium Revenue Market Share by Region (2020-2025)
Table 23. Global Heparin Sodium Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Heparin Sodium Revenue Market Share by Region (2026-2031)
Table 25. North America Heparin Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 27. North America Heparin Sodium Sales by Country (2026-2031) & (Million Units)
Table 28. North America Heparin Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Heparin Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Heparin Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 32. Europe Heparin Sodium Sales by Country (2026-2031) & (Million Units)
Table 33. Europe Heparin Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Heparin Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Heparin Sodium Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Heparin Sodium Sales by Region (2020-2025) & (Million Units)
Table 37. Asia Pacific Heparin Sodium Sales by Region (2026-2031) & (Million Units)
Table 38. Asia Pacific Heparin Sodium Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Heparin Sodium Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Heparin Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 42. Latin America Heparin Sodium Sales by Country (2026-2031) & (Million Units)
Table 43. Latin America Heparin Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Heparin Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Heparin Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 47. Middle East and Africa Heparin Sodium Sales by Country (2026-2031) & (Million Units)
Table 48. Middle East and Africa Heparin Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Heparin Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Heparin Sodium Sales (Million Units) by Type (2020-2025)
Table 51. Global Heparin Sodium Sales (Million Units) by Type (2026-2031)
Table 52. Global Heparin Sodium Sales Market Share by Type (2020-2025)
Table 53. Global Heparin Sodium Sales Market Share by Type (2026-2031)
Table 54. Global Heparin Sodium Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Heparin Sodium Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Heparin Sodium Revenue Market Share by Type (2020-2025)
Table 57. Global Heparin Sodium Revenue Market Share by Type (2026-2031)
Table 58. Global Heparin Sodium Price (USD/Million Units) by Type (2020-2025)
Table 59. Global Heparin Sodium Price (USD/Million Units) by Type (2026-2031)
Table 60. Global Heparin Sodium Sales (Million Units) by Application (2020-2025)
Table 61. Global Heparin Sodium Sales (Million Units) by Application (2026-2031)
Table 62. Global Heparin Sodium Sales Market Share by Application (2020-2025)
Table 63. Global Heparin Sodium Sales Market Share by Application (2026-2031)
Table 64. Global Heparin Sodium Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Heparin Sodium Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Heparin Sodium Revenue Market Share by Application (2020-2025)
Table 67. Global Heparin Sodium Revenue Market Share by Application (2026-2031)
Table 68. Global Heparin Sodium Price (USD/Million Units) by Application (2020-2025)
Table 69. Global Heparin Sodium Price (USD/Million Units) by Application (2026-2031)
Table 70. Shenzhen Hepalink Company Information
Table 71. Shenzhen Hepalink Description and Business Overview
Table 72. Shenzhen Hepalink Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 73. Shenzhen Hepalink Heparin Sodium Product
Table 74. Shenzhen Hepalink Recent Developments/Updates
Table 75. Nanjing King-friend Company Information
Table 76. Nanjing King-friend Description and Business Overview
Table 77. Nanjing King-friend Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 78. Nanjing King-friend Heparin Sodium Product
Table 79. Nanjing King-friend Recent Developments/Updates
Table 80. Bioiberica Company Information
Table 81. Bioiberica Description and Business Overview
Table 82. Bioiberica Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 83. Bioiberica Heparin Sodium Product
Table 84. Bioiberica Recent Developments/Updates
Table 85. Dongcheng Biochemicals Company Information
Table 86. Dongcheng Biochemicals Description and Business Overview
Table 87. Dongcheng Biochemicals Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 88. Dongcheng Biochemicals Heparin Sodium Product
Table 89. Dongcheng Biochemicals Recent Developments/Updates
Table 90. Changzhou Qianhong Bio-pharma Company Information
Table 91. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 92. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 93. Changzhou Qianhong Bio-pharma Heparin Sodium Product
Table 94. Changzhou Qianhong Bio-pharma Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 98. Pfizer Heparin Sodium Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Changshan Biochemical Company Information
Table 101. Changshan Biochemical Description and Business Overview
Table 102. Changshan Biochemical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 103. Changshan Biochemical Heparin Sodium Product
Table 104. Changshan Biochemical Recent Developments/Updates
Table 105. Aspen Oss Company Information
Table 106. Aspen Oss Description and Business Overview
Table 107. Aspen Oss Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 108. Aspen Oss Heparin Sodium Product
Table 109. Aspen Oss Recent Developments/Updates
Table 110. Opocrin Company Information
Table 111. Opocrin Description and Business Overview
Table 112. Opocrin Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 113. Opocrin Heparin Sodium Product
Table 114. Opocrin Recent Developments/Updates
Table 115. Qingdao Jiulong Biopharmaceutical Company Information
Table 116. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 117. Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 118. Qingdao Jiulong Biopharmaceutical Heparin Sodium Product
Table 119. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 120. Yino Pharma Limited Company Information
Table 121. Yino Pharma Limited Description and Business Overview
Table 122. Yino Pharma Limited Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 123. Yino Pharma Limited Heparin Sodium Product
Table 124. Yino Pharma Limited Recent Developments/Updates
Table 125. Dongying Tiandong Pharmaceutical Company Information
Table 126. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 127. Dongying Tiandong Pharmaceutical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 128. Dongying Tiandong Pharmaceutical Heparin Sodium Product
Table 129. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 130. Xinbai Pharmaceuticals Company Information
Table 131. Xinbai Pharmaceuticals Description and Business Overview
Table 132. Xinbai Pharmaceuticals Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 133. Xinbai Pharmaceuticals Heparin Sodium Product
Table 134. Xinbai Pharmaceuticals Recent Developments/Updates
Table 135. Laboratorios Farmaceuticos ROVI Company Information
Table 136. Laboratorios Farmaceuticos ROVI Description and Business Overview
Table 137. Laboratorios Farmaceuticos ROVI Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 138. Laboratorios Farmaceuticos ROVI Heparin Sodium Product
Table 139. Laboratorios Farmaceuticos ROVI Recent Developments/Updates
Table 140. Sichuan Deebio Company Information
Table 141. Sichuan Deebio Description and Business Overview
Table 142. Sichuan Deebio Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 143. Sichuan Deebio Heparin Sodium Product
Table 144. Sichuan Deebio Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Heparin Sodium Distributors List
Table 148. Heparin Sodium Customers List
Table 149. Heparin Sodium Market Trends
Table 150. Heparin Sodium Market Drivers
Table 151. Heparin Sodium Market Challenges
Table 152. Heparin Sodium Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Heparin Sodium
Figure 2. Global Heparin Sodium Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Heparin Sodium Market Share by Type: 2024 & 2031
Figure 4. Type A Product Picture
Figure 5. Type B Product Picture
Figure 6. Global Heparin Sodium Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Heparin Sodium Market Share by Application: 2024 & 2031
Figure 8. Standard Heparin Preparation
Figure 9. Low Molecular Weight Heparin Preparations
Figure 10. Global Heparin Sodium Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Heparin Sodium Market Size (2020-2031) & (US$ Million)
Figure 12. Global Heparin Sodium Sales (2020-2031) & (Million Units)
Figure 13. Global Heparin Sodium Average Price (USD/Million Units) & (2020-2031)
Figure 14. Heparin Sodium Report Years Considered
Figure 15. Heparin Sodium Sales Share by Manufacturers in 2024
Figure 16. Global Heparin Sodium Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Heparin Sodium Players: Market Share by Revenue in Heparin Sodium in 2024
Figure 18. Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Heparin Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Heparin Sodium Sales Market Share by Country (2020-2031)
Figure 21. North America Heparin Sodium Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Heparin Sodium Sales Market Share by Country (2020-2031)
Figure 25. Europe Heparin Sodium Revenue Market Share by Country (2020-2031)
Figure 26. Germany Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Heparin Sodium Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Heparin Sodium Revenue Market Share by Region (2020-2031)
Figure 33. China Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Heparin Sodium Sales Market Share by Country (2020-2031)
Figure 44. Latin America Heparin Sodium Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Heparin Sodium Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Heparin Sodium Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Heparin Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Heparin Sodium by Type (2020-2031)
Figure 54. Global Revenue Market Share of Heparin Sodium by Type (2020-2031)
Figure 55. Global Heparin Sodium Price (USD/Million Units) by Type (2020-2031)
Figure 56. Global Sales Market Share of Heparin Sodium by Application (2020-2031)
Figure 57. Global Revenue Market Share of Heparin Sodium by Application (2020-2031)
Figure 58. Global Heparin Sodium Price (USD/Million Units) by Application (2020-2031)
Figure 59. Heparin Sodium Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Heparin Sodium in 2031?
The global market size of Heparin Sodium in 2031 was 4560 Million USD.
What is the annual compound growth rate of the global Heparin Sodium market size from 2025 to 2031?
Which companies rank high in the global Heparin Sodium market?
Which region is expected to have the highest market share?
What was the global market size of Heparin Sodium in 2025?
Related Reports
Global Heparin Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin Sodium market size was US$ 3185 million in 2025 and is forecast to reach a readjusted size of US$ 4812 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 94
USD 4250.00
(Single User License)
Global Heparin Sodium Market Research Report 2026
The global Heparin Sodium market was valued at US$ 3185 million in 2025 and is anticipated to reach US$ 4812 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 125
USD 2900.00
(Single User License)
Heparin Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin Sodium was estimated to be worth US$ 3185 million in 2025 and is projected to reach US$ 4812 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 3950.00
(Single User License)
Global Heparin Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin Sodium market is projected to grow from US$ 3018 million in 2024 to US$ 4560 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 159
USD 4900.00
(Single User License)
Global Heparin Sodium Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin Sodium was estimated to be worth US$ 3018 million and is forecast to reach approximately US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 150
USD 5900.00
(Single User License)
Global Heparin Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin Sodium market size was US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 93
USD 4250.00
(Single User License)
Heparin Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin Sodium was estimated to be worth US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 130
USD 3950.00
(Single User License)
Global Heparin Sodium Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Heparin Sodium Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published Date: 2024-04-16
Pages: 172
USD 5900.00
(Single User License)
Global Heparin Sodium Market Insights, Forecast to 2030
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published Date: 2024-04-07
Pages: 112
USD 4900.00
(Single User License)
Global Heparin Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin Sodium market size was US$ 3185 million in 2025 and is forecast to reach a readjusted size of US$ 4812 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 94
USD 4250.00 (Single User License)Global Heparin Sodium Market Research Report 2026
The global Heparin Sodium market was valued at US$ 3185 million in 2025 and is anticipated to reach US$ 4812 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 125
USD 2900.00 (Single User License)Heparin Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin Sodium was estimated to be worth US$ 3185 million in 2025 and is projected to reach US$ 4812 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 3950.00 (Single User License)Global Heparin Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin Sodium market is projected to grow from US$ 3018 million in 2024 to US$ 4560 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 159
USD 4900.00 (Single User License)Global Heparin Sodium Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin Sodium was estimated to be worth US$ 3018 million and is forecast to reach approximately US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 150
USD 5900.00 (Single User License)Global Heparin Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin Sodium market size was US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 93
USD 4250.00 (Single User License)Heparin Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin Sodium was estimated to be worth US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 130
USD 3950.00 (Single User License)Global Heparin Sodium Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)Global Heparin Sodium Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published: 2024-04-16
Pages: 172
USD 5900.00 (Single User License)Global Heparin Sodium Market Insights, Forecast to 2030
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published: 2024-04-07
Pages: 112
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now